Additionally, our gene-drug interaction analysis identified three compounds that target Cybb. Taken together, these data suggest Cybb is at the intersection of cardiovascular disease, diabetes, and neuroinflammation, making it an attractive potential target for further investigation. This evidence concerns the gene CYBB and diabetes mellitus.